Anemia Features

Expert Q&A Renal Stenting and the CORAL Study: Interview with Lance Dworkin, MD

Renal Stenting and the CORAL Study: Interview with Lance Dworkin, MD

CORAL study chair Lance Dworkin, MD, discusses the controversial finding with Renal & Urology News.

Departments Guidelines and the Older Patient with CKD

Guidelines and the Older Patient with CKD

Geriatric patients with CKD are at high risk for morbidity and mortality from the potential side effects of treatments.

The Medical Minute Some Anemic Kids on Dialysis Are at Higher Death Risk

Some Anemic Kids on Dialysis Are at Higher Death Risk

Children on dialysis who have anemia and require high doses of drugs to treat it are at increased risk of dying prematurely.

Latest Anemia News

CMV in Kidney Disease Linked with Anemia

CMV in Kidney Disease Linked with Anemia

Patients with higher levels of anti-CMV antibodies have lower number of red blood cells.

ESA Resistance Found To Increase Mortality

Greater resistance to ESA is associated with an increased risk of death among patients on chronic HD.

MI-Acquired Anemia Rates Vary by Hospital

MI-Acquired Anemia Rates Vary by Hospital

Considerable variation in incidence of HAA across hospitals; teaching status and region linked to risk.

Ribavirin May Treat HEV Infection in Transplant Recipients

Ribavirin May Treat HEV Infection in Transplant Recipients

Serum hepatitis E virus levels were undetectable in 78% of patients at least 6 months after stopping treatment.

IV Iron Drugs Demonstrate Similar Efficacy, AE Rates

Ferumoxytol and iron sucrose have comparable safety in the treatment of anemia in patients with CKD.

Low Iron Tied to Higher Stroke Risk

Low Iron Tied to Higher Stroke Risk

Platelets may aggregate more easily in iron-deficient patients.

Novel Iron Compound Patented in Japan

Novel Iron Compound Patented in Japan

Soluble ferric pyrophosphate (Triferic), an investigational drug, is delivered to hemodialysis patients via dialysate.

IV Iron Drugs Demonstrate Similar Efficacy, Safety in CKD Patients

IV Iron Drugs Demonstrate Similar Efficacy, Safety in CKD Patients

In a study, ferumoxytol and iron sucrose treatment was associated with comparable increases in hemoglobin levels and adverse event rates.

Sickle Cell Trait May Raise Need for Anemia Meds in Dialysis Patients

Sickle Cell Trait May Raise Need for Anemia Meds in Dialysis Patients

This trait in African-American hemodialysis patients was associated with a 13.2% higher dose of erythropoiesis-stimulating agents.

Iron Status Affects Platelet Counts in Hemodialysis Patients

Decreasing TSAT and higher ESA doses are associated with increasing platelet counts.

Anemic Peritoneal Dialysis Patients May Benefit from Folic Acid

Folic acid treatment significantly improved hemoglobin levels and decreased epoetin alfa use.

Phosphate Binder Found to Cut IV Iron, ESA Use

Elemental iron requirement was reduced by half in patients receiving ferric citrate versus an active control.

Changes in U.S. Anemia Management Not Seen in Europe, Japan

These include use of lower ESA doses and hemoglobin levels.

Intradialytic Exercise May Improve Renal Anemia in the Elderly

Weekly dose of erythropoiesis-stimulating agents decreased and hemoglobin levels increased.

Low Hemoglobin Hikes Mortality in Pediatric Dialysis Patients

Patients with levels below 10 g/dL had the highest unadjusted mortality and all-cause hospitalization rates.